• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板减少症与早产儿视网膜病变

Thrombocytopenia and retinopathy of prematurity.

作者信息

Jensen Anne K, Ying Gui-Shuang, Huang Jiayan, Karp Karen, Quinn Graham E, Binenbaum Gil

机构信息

Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

出版信息

J AAPOS. 2011 Feb 1;15(1):e3-e4. doi: 10.1016/j.jaapos.2011.07.006.

DOI:10.1016/j.jaapos.2011.07.006
PMID:22025899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3197807/
Abstract

BACKGROUND

Platelets may act as vascular endothelial growth factor (VEGF) scavengers, possibly limiting neovascularization in retinopathy of prematurity (ROP). The purpose of this study was to investigate the association between thrombocytopenia (platelets <150,000/μL) and the development of type 1 ROP. METHODS: This was a retrospective 1:1 matched case-control study. Cases required laser; controls developed no or stage 1 ROP and were matched for birth weight within 100 g and gestational age within 1 week. Most recent platelet count prior to laser (case) and matched postmenstrual age (control) were abstracted. Conditional logistic regression was used. RESULTS: A total of 91 cases and 91 controls were reviewed. Of the cases, 25% had thrombocytopenia; of controls, 13% (P = 0.034; OR = 2.38; 95% CI, 1.04-5.43). Birth weight, gestational age, postmenstrual age, and culture-proven sepsis were not confounders in multivariate analysis. The association was significant for zone 1 (n = 16; OR = 9.00; 95% CI, 1.14-71.0) but not for zone 2 (OR = 1.43; 95% CI, 0.54-3.75) cases and controls. CONCLUSIONS: Thrombocytopenia was associated with type 1 ROP, primarily among infants with zone 1 ROP. This effect may result from disease location or disease timing, as posterior disease occurs at an earlier postmenstrual age. Longitudinal studies are required to further examine the roles of cumulative platelet deficits, thresholds, or critical time windows in the observed association.

摘要

背景

血小板可能作为血管内皮生长因子(VEGF)清除剂,可能限制早产儿视网膜病变(ROP)中的新生血管形成。本研究的目的是调查血小板减少症(血小板<150,000/μL)与1型ROP发生之间的关联。方法:这是一项回顾性1:1匹配病例对照研究。病例需要进行激光治疗;对照未发生或为1期ROP,且出生体重相差100 g以内、胎龄相差1周以内进行匹配。提取激光治疗前(病例)和匹配的月经后年龄(对照)时的最新血小板计数。采用条件逻辑回归分析。结果:共纳入91例病例和91例对照。病例组中,25%有血小板减少症;对照组中,13%(P = 0.034;OR = 2.38;95%CI,1.04 - 5.43)。出生体重、胎龄、月经后年龄和经培养证实的败血症在多因素分析中不是混杂因素。该关联在1区病例(n = 16;OR = 9.00;95%CI,1.14 - 71.0)中显著,但在2区病例和对照中不显著(OR = 1.43;95%CI,0.54 - 3.75)。结论:血小板减少症与1型ROP相关,主要发生在1区ROP婴儿中。这种效应可能是由于疾病部位或疾病发生时间,因为后部疾病在较早的月经后年龄发生。需要进行纵向研究以进一步研究累积血小板缺乏、阈值或关键时间窗在观察到的关联中的作用。

相似文献

1
Thrombocytopenia and retinopathy of prematurity.血小板减少症与早产儿视网膜病变
J AAPOS. 2011 Feb 1;15(1):e3-e4. doi: 10.1016/j.jaapos.2011.07.006.
2
Longitudinal study of the association between thrombocytopenia and retinopathy of prematurity.血小板减少症与早产儿视网膜病变关联的纵向研究
J AAPOS. 2018 Apr;22(2):119-123. doi: 10.1016/j.jaapos.2017.11.009. Epub 2018 Mar 14.
3
Is thrombocytopenia and postnatal weight gain associated with treatment-requiring retinopathy of prematurity? A matched case-control study.血小板减少症和出生后体重增加与需要治疗的早产儿视网膜病变有关吗?一项配对病例对照研究。
Acta Ophthalmol. 2023 Jun;101(4):433-442. doi: 10.1111/aos.15302. Epub 2022 Dec 5.
4
Thrombocytopenia is associated with severe retinopathy of prematurity.血小板减少症与严重早产儿视网膜病变有关。
JCI Insight. 2018 Oct 4;3(19):99448. doi: 10.1172/jci.insight.99448.
5
THROMBOCYTOPENIA AS A RISK FACTOR FOR RETINOPATHY OF PREMATURITY.血小板减少症与早产儿视网膜病变的相关性研究
Retina. 2019 Apr;39(4):706-711. doi: 10.1097/IAE.0000000000002028.
6
[Effects of intravitreal pegaptanib or bevacizumab and laser in treatment of threshold retinopathy of prematurity in zone I and posterior zone II--four years results].玻璃体内注射培加他尼或贝伐单抗联合激光治疗Ⅰ区和Ⅱ区后部阈值早产儿视网膜病变的四年结果
Cesk Slov Oftalmol. 2012 Feb;68(1):29-36.
7
Relationship between mean platelet volume and retinopathy of prematurity.平均血小板体积与早产儿视网膜病变之间的关系。
Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1791-4. doi: 10.1007/s00417-015-2972-8. Epub 2015 Mar 8.
8
Aggressive Posterior Retinopathy of Prematurity Is Associated with Multiple Infectious Episodes and Thrombocytopenia.侵袭性早产儿视网膜病变与多次感染发作及血小板减少症相关。
Neonatology. 2017;111(1):79-85. doi: 10.1159/000448161. Epub 2016 Sep 16.
9
Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.用于治疗早产儿视网膜病变的抗血管内皮生长因子(VEGF)药物。
Cochrane Database Syst Rev. 2018 Jan 8;1(1):CD009734. doi: 10.1002/14651858.CD009734.pub3.
10
The association of platelet counts with development and treatment for retinopathy of prematurity - is thrombocytopenia a risk factor?血小板计数与早产儿视网膜病变的发生及治疗的关联——血小板减少症是一个危险因素吗?
Arch Med Sci. 2019 May 27;18(2):400-405. doi: 10.5114/aoms.2019.85386. eCollection 2022.

引用本文的文献

1
Adenosine diphosphate stimulates VEGF-independent choroidal endothelial cell proliferation: A potential escape from anti-VEGF therapy.二磷酸腺苷刺激不依赖血管内皮生长因子的脉络膜内皮细胞增殖:抗血管内皮生长因子治疗的潜在逃逸机制
Proc Natl Acad Sci U S A. 2025 Jan 28;122(4):e2418752122. doi: 10.1073/pnas.2418752122. Epub 2025 Jan 21.
2
Predictive value of serum inflammatory markers in retinopathy of prematurity.血清炎症标志物在早产儿视网膜病变中的预测价值。
Eye (Lond). 2024 Oct;38(14):2822-2826. doi: 10.1038/s41433-024-03260-5. Epub 2024 Jul 25.
3
Predictive role of systemic immune-inflammation index and neutrophil/lymphocyte ratio values in infants with retinopathy of prematurity.全身免疫炎症指数和中性粒细胞/淋巴细胞比值对早产儿视网膜病变的预测作用。
Graefes Arch Clin Exp Ophthalmol. 2024 Oct;262(10):3125-3134. doi: 10.1007/s00417-024-06493-y. Epub 2024 Apr 24.
4
Biomarkers in retinopathy of prematurity: a systematic review and meta-analysis.早产儿视网膜病变中的生物标志物:一项系统评价与荟萃分析。
Front Pediatr. 2024 Mar 20;12:1371776. doi: 10.3389/fped.2024.1371776. eCollection 2024.
5
Platelet Counts and Risk of Severe Retinopathy of Prematurity: A Bayesian Model-Averaged Meta-Analysis.血小板计数与早产儿严重视网膜病变风险:一项贝叶斯模型平均荟萃分析
Children (Basel). 2023 Dec 8;10(12):1903. doi: 10.3390/children10121903.
6
Retinopathy of prematurity among infants admitted to two neonatal intensive care units in Ethiopia.早产儿视网膜病变:在埃塞俄比亚两家新生儿重症监护病房接受治疗的婴儿。
BMJ Open Ophthalmol. 2023 Jul;8(1). doi: 10.1136/bmjophth-2023-001257.
7
Complete blood count parameters as biomarkers of retinopathy of prematurity: a Portuguese multicenter study.全血细胞计数参数作为早产儿视网膜病变的生物标志物:一项葡萄牙多中心研究。
Graefes Arch Clin Exp Ophthalmol. 2023 Oct;261(10):2997-3006. doi: 10.1007/s00417-023-06072-7. Epub 2023 May 2.
8
Assessment of Role of Platelet Indices in the Occurrence of Retinopathy of Prematurity.评估血小板指标在早产儿视网膜病变发生中的作用。
Middle East Afr J Ophthalmol. 2023 Feb 24;29(2):91-95. doi: 10.4103/meajo.meajo_246_21. eCollection 2022 Apr-Jun.
9
Clinical parameters in different stages, zones, and remission/progression statuses of retinopathy of prematurity.早产儿视网膜病变不同阶段、区域及缓解/进展状态的临床参数。
Caspian J Intern Med. 2022 Spring;13(2):385-392. doi: 10.22088/cjim.13.2.10.
10
The Role of Thrombocyte Parameters in Retinopathy of Prematurity Development.血小板参数在早产儿视网膜病变发展中的作用。
Int J Clin Pract. 2022 Jan 31;2022:7518533. doi: 10.1155/2022/7518533. eCollection 2022.

本文引用的文献

1
Do platelets have a role in the pathogenesis of aggressive posterior retinopathy of prematurity?血小板在早产儿后部进行性视网膜病变的发病机制中起作用吗?
Retina. 2010 Apr;30(4 Suppl):S20-3. doi: 10.1097/IAE.0b013e3181cafc30.
2
New insights into the development of retinopathy of prematurity--importance of early weight gain.早产儿视网膜病变的新见解——早期体重增加的重要性。
Acta Paediatr. 2010 Apr;99(4):502-8. doi: 10.1111/j.1651-2227.2009.01568.x. Epub 2009 Oct 29.
3
Neonatal thrombocytopenia: what we do and don't know.新生儿血小板减少症:我们所知道和不知道的情况。
Early Hum Dev. 2008 Aug;84(8):499-506. doi: 10.1016/j.earlhumdev.2008.06.004. Epub 2008 Aug 5.
4
Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control.早产儿视网膜病变:关于该流行病的全球视角、高危婴儿群体及防控意义
Early Hum Dev. 2008 Feb;84(2):77-82. doi: 10.1016/j.earlhumdev.2007.11.009. Epub 2008 Jan 29.
5
Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released.血管生成受一种新机制调控:促血管生成蛋白和抗血管生成蛋白被分别组织在血小板α颗粒中,并以不同方式释放。
Blood. 2008 Feb 1;111(3):1227-33. doi: 10.1182/blood-2007-09-113837. Epub 2007 Oct 25.
6
Angiogenesis: an organizing principle for drug discovery?血管生成:药物发现的一个组织原则?
Nat Rev Drug Discov. 2007 Apr;6(4):273-86. doi: 10.1038/nrd2115.
7
Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs.低、中、高发展水平国家中患有严重早产儿视网膜病变的婴儿特征:对筛查项目的启示
Pediatrics. 2005 May;115(5):e518-25. doi: 10.1542/peds.2004-1180. Epub 2005 Apr 1.
8
Pathogenesis of retinopathy of prematurity.早产儿视网膜病变的发病机制。
Growth Horm IGF Res. 2004 Jun;14 Suppl A:S140-4. doi: 10.1016/j.ghir.2004.03.030.
9
Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.早产儿视网膜病变治疗的修订指征:早产儿视网膜病变早期治疗随机试验结果
Arch Ophthalmol. 2003 Dec;121(12):1684-94. doi: 10.1001/archopht.121.12.1684.
10
Blindness in children: control priorities and research opportunities.儿童失明:控制重点与研究机会
Br J Ophthalmol. 2001 Sep;85(9):1025-7. doi: 10.1136/bjo.85.9.1025.